Calling all medical students. Would you like to win £750?
Calling all medical students! How would you rate your knowledge of ovarian cancer?
Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Calling all medical students! How would you rate your knowledge of ovarian cancer?
Time is running out: women's lives are being lost because of delays in ovarian cancer diagnosis, according to our new report.
Target Ovarian Cancer is announcing a brand new award for research into a less common type of this disease.
Jo lost her mum to ovarian cancer two years ago. Since then she resolved to work on her own health, and decided to take up running. She tells us how she went from running novice to completing the Bristol 10k...
Gamechanging drug olaparib is now available from beginning of treatment across the UK.
Mike is taking on an unusual challenge in memory of his wife Pam. He tells us about his motivation to fund research to make the future better for women with ovarian cancer...
Today we've released new research on how much women know about breast cancer and ovarian cancer symptoms.
New ovarian cancer drug rucaparib (Rubraca®) is now available on the NHS.
We look at what we're doing to transform GP knowledge of ovarian cancer to improve early diagnosis.
News from the European Society of Medical Oncology (ESMO) conference means more women could be able to access innovative treatments earlier.
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer
Sign up